JLL was established in 1981 marketing heart pacemakers. Since then,
the Group has expanded its product line to include surgical devices
and vascular interventional products.
JLL is one of a small number of companies that handle instruments
used to treat all areas of heart ailments. In 1997, JLL was listed
on the JASDAQ and began manufacturing operations in 2001.
Currently, the Company is a market leader in the distribution of
ablation catheters. The sales force includes more than 250
experienced and knowledgeable cardiovascular representatives who
work out of 27 regional sales offices, allowing complete coverage of
the nation’s medical facilities.